Picture of Spago Nanomedical AB (publ) logo

SPAGO Spago Nanomedical AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Advisory: Alerts on positive data in Spago's phase IIa endometriosis trial repeat earlier story

Dec 20 (Reuters) - Please ignore alerts on positive data in Spago's  SPAGO.ST  phase IIa
endometriosis trial. The alerts repeat earlier story from Dec. 15, 2023 and will be withdrawn.
To see Reuters coverage of the news please follow the link  urn:newsml:reuters.com:*:nFWN3D94J4

    
STORY_NUMBER: FWN3DE1F8 
STORY_DATE: 20/12/2023 
STORY_TIME: 07:46:24 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Spago Nanomedical AB (publ)

See all news